“…With the advent of new molecular biology assays, further characterization of ACF genetic profiles to assess their risks of progression to cancers are possible [ 44 ]. These categories consist of epigenetic silencing, genetic mutation, microsatellite instability and loss of heterozygosity ( Table 2 ) [ 45 , 46 , 47 , 48 , 49 , 50 , 51 , 52 , 53 , 54 , 55 , 56 , 57 , 58 , 59 , 60 , 61 , 62 , 63 , 64 , 65 , 66 , 67 ]. Epigenetic silencing of genes involved in cancers has been an area of intense research over the last decade [ 63 ].…”